Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Nanofibers in mucosal drug and vaccine delivery

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00027162%3A_____%2F20%3AN0000008" target="_blank" >RIV/00027162:_____/20:N0000008 - isvavai.cz</a>

  • Výsledek na webu

    <a href="https://www.intechopen.com/books/nanomaterials-toxicity-human-health-and-environment/nanofibers-in-mucosal-drug-and-vaccine-delivery" target="_blank" >https://www.intechopen.com/books/nanomaterials-toxicity-human-health-and-environment/nanofibers-in-mucosal-drug-and-vaccine-delivery</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.5772/intechopen.82279" target="_blank" >10.5772/intechopen.82279</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Nanofibers in mucosal drug and vaccine delivery

  • Popis výsledku v původním jazyce

    Successful mucosal administration and delivery of drugs still pose a great challenge. However, the possibility to deliver not only small drug molecules, but also macromolecular drugs and nanoparticles via mucosal surfaces represents a great opportunity. Rapid onset of drug action, avoidance of first-pass metabolism, and high immunocompetence of mucosa are some of the important features for mucosal drug and vaccine delivery. The use of mucoadhesive drug delivery systems, systems with fast-dissolving properties, and nanomaterials with mucus penetration properties are examples of successful strategies to achieve effective mucosal drug and vaccine delivery. Non-keratinised mucosa of the oral cavity, the nasal and vaginal mucosa represent favourable sites of drug administration. Polymer nanofibers have attracted much attention because of remarkable characteristics such as a large surface area to volume ratio and high porosity. Nanofibers have been extensively used for different biomedical applications including wound dressing, tissue engineering and drug delivery. Among their fabrication methods, the introduction of electrospinning technique was an important step towards achieving the goal of large scale industrial production of nanofiber-based drug delivery systems used in mucosal applications. This chapter provides an overview on all aspects of mucosal drug and vaccine delivery using nanofibers.

  • Název v anglickém jazyce

    Nanofibers in mucosal drug and vaccine delivery

  • Popis výsledku anglicky

    Successful mucosal administration and delivery of drugs still pose a great challenge. However, the possibility to deliver not only small drug molecules, but also macromolecular drugs and nanoparticles via mucosal surfaces represents a great opportunity. Rapid onset of drug action, avoidance of first-pass metabolism, and high immunocompetence of mucosa are some of the important features for mucosal drug and vaccine delivery. The use of mucoadhesive drug delivery systems, systems with fast-dissolving properties, and nanomaterials with mucus penetration properties are examples of successful strategies to achieve effective mucosal drug and vaccine delivery. Non-keratinised mucosa of the oral cavity, the nasal and vaginal mucosa represent favourable sites of drug administration. Polymer nanofibers have attracted much attention because of remarkable characteristics such as a large surface area to volume ratio and high porosity. Nanofibers have been extensively used for different biomedical applications including wound dressing, tissue engineering and drug delivery. Among their fabrication methods, the introduction of electrospinning technique was an important step towards achieving the goal of large scale industrial production of nanofiber-based drug delivery systems used in mucosal applications. This chapter provides an overview on all aspects of mucosal drug and vaccine delivery using nanofibers.

Klasifikace

  • Druh

    C - Kapitola v odborné knize

  • CEP obor

  • OECD FORD obor

    20101 - Civil engineering

Návaznosti výsledku

  • Projekt

    Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

  • Návaznosti

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Ostatní

  • Rok uplatnění

    2020

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název knihy nebo sborníku

    Nanomaterials: Toxicity, Human Health and Environment

  • ISBN

    978-1-78984-616-4

  • Počet stran výsledku

    28

  • Strana od-do

    171-198

  • Počet stran knihy

    231

  • Název nakladatele

    IntechOpen

  • Místo vydání

    London, UK

  • Kód UT WoS kapitoly